<DOC>
	<DOCNO>NCT01964807</DOCNO>
	<brief_summary>The overarch goal project develop panel cardiovascular risk biomarkers detect difference cardiovascular safety various tobacco product , whether conventional , new emerging , order help FDA task regulating . This achieve 4 aim : Aim 1 : Determine relative contribution nicotine combustion product cardiovascular risk active cigarette smoking . Aim 2 : Determine cardiovascular risk biomarkers affect exposure secondhand smoke . Aim 3 : Determine cardiovascular risk smokeless tobacco use . Aim 4 : Determine cardiovascular risk electronic cigarette respective contribution nicotine electronic cigarette vapor .</brief_summary>
	<brief_title>Cardiovascular Assessment Effects Tobacco Nicotine Delivery Products</brief_title>
	<detailed_description>Cigarette smoke major cause cardiovascular disease ( CVD ) .1 In contrast , cardiovascular risk popular tobacco product ( smokeless tobacco ) , new tobacco product ( e-cigarettes ) propose product ( reduce nicotine cigarette ) adequately understood . The FDA need information cardiovascular safety product inform regulatory decision . While long-term clinical outcome study cardiovascular risk tobacco product would optimal , take long provide data FDA need . Disturbances function vascular endothelium ( line artery , play important role regulate vascular function ) activation autonomic nervous system , well increased inflammation , oxidative stress propensity thrombosis ( clot ) , key mechanism progression CVD validate biomarkers CVD risk . These biomarkers form basis model ass CVD risk tobacco product use secondhand smoke exposure . We conduct control , short-term exposure human subject test product provide wide range nicotine , particle , cardiovascular toxin concentration determine component associate tobacco use adversely affect cardiovascular risk .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<criteria>All Groups : Age 1850 Can tolerate withholding medication two week time Group 1 : Active smoker Group 2 : Nonsmokers Group 3 : Active user smokeless tobacco Group 4 : Active user electronic cigarette Additional Inclusion Criteria ECigarette Users : Currently use ofecigarettes &gt; 5 time day Has use ecigarettes &gt; 3 month Additional Inclusion Criteria Active Smokers : Currently smoke &gt; 5 cigarette per day â‰¥ 1 pack year Exclusion Criteria subject Physician diagnosis : asthma heart disease hypertension dyslipidemia thyroid disease diabetes renal liver impairment glaucoma . Unstable psychiatric condition ( current major depression , history schizophrenia bipolar disorder ) current use two psychiatric medication Pregnancy breastfeeding ( history ) Alcohol , opiate , cocaine , amphetamine methamphetamine dependence within past 5 year BMI &gt; 35 &lt; 18 Current opiate , cocaine , amphetamine methamphetamine use ( history urine test ) Occupational exposure smoke , dust fumes Concurrent participation another clinical trial Unable communicate English Additional Exclusion Criteria Active Smokers : Unable hold marijuana 1 week prior study visit . Exhaled CO &lt; 10 ppm visit Negative salivary cotinine test use rapidread , counter test 30 ng/ml cutoff Additional Exclusion Criteria Nonsmokers : More 1 pack year smoke history Quit smoking &lt; 5 year ago Ever daily marijuana smoker Smoked anything within last 3 month Additional Inclusion Criteria Smokeless Tobacco Users : Use moist oral snuff &gt; 5 time day Has use moist oral snuff least 0.5 year Additional Exclusion Criteria Smokeless Tobacco Users : Current smoker Quit smoking &lt; 0.5 year ago Additional Exclusion Criteria ECigarette Users : Current use tobacco product Unable hold marijuana 1 week prior study visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Cardiovascular</keyword>
	<keyword>tobacco</keyword>
	<keyword>cigarette</keyword>
	<keyword>secondhand cigarette smoke</keyword>
	<keyword>SHS</keyword>
	<keyword>smokeless tobacco</keyword>
	<keyword>chew tobacco</keyword>
	<keyword>snus</keyword>
	<keyword>electronic cigarette</keyword>
	<keyword>vapor</keyword>
	<keyword>particle</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>flow-mediated dilation</keyword>
	<keyword>FMD</keyword>
</DOC>